litlas
ログインアカウント作成

Gary Remington

1979–2025 年に発表

137
論文数
18,303
被引用数
81
h 指数
135
i10 指数

被引用数

Gary Remington の年別被引用数1979 年: 被引用 6 件1980 年: 被引用 5 件1981 年: 被引用 8 件1982 年: 被引用 7 件1983 年: 被引用 3 件1984 年: 被引用 4 件1985 年: 被引用 3 件1986 年: 被引用 2 件1987 年: 被引用 5 件1988 年: 被引用 3 件1989 年: 被引用 3 件1990 年: 被引用 2 件1991 年: 被引用 3 件1992 年: 被引用 3 件1993 年: 被引用 4 件1994 年: 被引用 7 件1995 年: 被引用 20 件1996 年: 被引用 13 件1997 年: 被引用 32 件1998 年: 被引用 27 件1999 年: 被引用 63 件2000 年: 被引用 41 件2001 年: 被引用 58 件2002 年: 被引用 66 件2003 年: 被引用 78 件2004 年: 被引用 95 件2005 年: 被引用 100 件2006 年: 被引用 120 件2007 年: 被引用 108 件2008 年: 被引用 126 件2009 年: 被引用 103 件2010 年: 被引用 98 件2011 年: 被引用 119 件2012 年: 被引用 126 件2013 年: 被引用 129 件2014 年: 被引用 139 件2015 年: 被引用 135 件2016 年: 被引用 166 件2017 年: 被引用 174 件2018 年: 被引用 137 件2019 年: 被引用 512 件2020 年: 被引用 507 件2021 年: 被引用 478 件2022 年: 被引用 404 件2023 年: 被引用 301 件2024 年: 被引用 508 件2025 年: 被引用 211 件2026 年: 被引用 9 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,563 件、この内訳の 23.4%イギリス: 引用元論文 700 件、この内訳の 10.5%カナダ: 引用元論文 598 件、この内訳の 9%ドイツ: 引用元論文 409 件、この内訳の 6.1%イタリア: 引用元論文 309 件、この内訳の 4.6%中国: 引用元論文 282 件、この内訳の 4.2%オーストラリア: 引用元論文 277 件、この内訳の 4.2%スペイン: 引用元論文 209 件、この内訳の 3.1%オランダ: 引用元論文 174 件、この内訳の 2.6%日本: 引用元論文 171 件、この内訳の 2.6%スイス: 引用元論文 165 件、この内訳の 2.5%フランス: 引用元論文 163 件、この内訳の 2.4%
0%23.4%その他 24.8%

機関

分野

  • Medicine58.2%
  • Neuroscience27.3%
  • Biochemistry, Genetics and Molecular Biology6.7%
  • Psychology4.5%
  • Computer Science0.7%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • その他2%

トピック

  • Schizophrenia research and treatment18.3%
  • Tryptophan and brain disorders5.6%
  • Neurotransmitter Receptor Influence on Behavior5%
  • Bipolar Disorder and Treatment4%
  • Functional Brain Connectivity Studies3.4%
  • Mental Health and Psychiatry3.4%
  • その他60.3%

共著者

全論文

検索で開く
  1. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

    著者: Oliver Howes, Robert A. McCutcheon, Ofer Agid, Andrea de Bartolomeis, Nico J.M. van Beveren, Michael L. Birnbaum, Michael Bloomfield, Rodrigo A. Bressan, Robert W. Buchanan, William T. Carpenter, David Castle, Leslie Citrome, Zafiris J. Daskalakis, Michael Davidson, Richard Drake, Serdar Dursun, Bjørn H. Ebdrup, Hélio Elkis, Peter Falkai, W. Wolfgang Fleischacker, Ary Gadelha, Fiona Gaughran, Birte Glenthøj, Ariel Graff‐Guerrero, Jorge Hallak, William G. Honer, James L. Kennedy, Bruce J. Kinon, Stephen M. Lawrie, Jimmy Lee, F. Markus Leweke, James H. MacCabe, Carolyn McNabb, Herbert Y. Meltzer, Hans‐Jürgen Möller, Shinchiro Nakajima, Christos Pantelis, Tiago Reis Marques, Gary Remington, Susan L. Rossell, Bruce R. Russell, Cynthia Siu, Takefumi Suzuki, Iris E. Sommer, David Taylor, Neil Thomas, Alp Üçok, Daniel Umbricht, James Walters, John M. Kane, Christoph U. Correll - American Journal of Psychiatry 2016 被引用: 1,106

  2. Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis

    著者: Eric Plitman, Yusuke Iwata, Fernando Caravaggio, Shinichiro Nakajima, Jun Ku Chung, Philip Gerretsen, Julia Kim, Hiroyoshi Takeuchi, M. Mallar Chakravarty, Gary Remington, Ariel Graff‐Guerrero - Schizophrenia Bulletin 2017 被引用: 244

  3. Guidelines for the Pharmacotherapy of Schizophrenia in Adults

    著者: Gary Remington, Donald Addington, William G. Honer, Zahinoor Ismail, Thomas J. Raedler, Michael D. Teehan - The Canadian Journal of Psychiatry 2017 被引用: 322

  4. Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia

    著者: Shitij Kapur, Robert B. Zipursky, Corey Jones, Gary Remington, Sylvain Houle - American Journal of Psychiatry 2000 被引用: 1,083

  5. Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health

    著者: Nicolette Stogios, Alexander Gdanski, Philip Gerretsen, Araba Chintoh, Ariel Graff‐Guerrero, Tarek K. Rajji, Gary Remington, Margaret Hahn, Sri Mahavir Agarwal - Schizophrenia 2021 被引用: 93

  6. Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series

    著者: Femin Prasad, Riddhita De, Vittal Korann, Araba Chintoh, Gary Remington, Bjørn H. Ebdrup, Dan Siskind, Filip K. Knop, Tina Vilsbøll, Anders Fink‐Jensen, Margaret Hahn, Sri Mahavir Agarwal - Therapeutic Advances in Psychopharmacology 2023 被引用: 86

  7. Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia

    著者: Nicole E. MacKenzie, Chantel Kowalchuk, Sri Mahavir Agarwal, Kenya A. Costa-Dookhan, Fernando Caravaggio, Philip Gerretsen, Araba Chintoh, Gary Remington, Valerie H. Taylor, Daniel J. Müller, Ariel Graff‐Guerrero, Margaret Hahn - Frontiers in Psychiatry 2018 被引用: 207

  8. Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophrenia

    著者: Hiroyoshi Takeuchi, Cynthia Siu, Gary Remington, Gagan Fervaha, Robert B. Zipursky, George Foussias, Ofer Agid - Neuropsychopharmacology 2018 被引用: 201

  9. Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group

    著者: Elias Wagner, Dan Siskind, Peter Falkai, Oliver Howes, Christoph U. Correll, Jimmy Lee, William G. Honer, John M. Kane, Emilio Fernández-Egea, Thomas R. E. Barnes, Alkomiet Hasan, TRRIP Working Group, Ofer Agid, Celso Arango, Lone Baandrup, Thomas R. E. Barnes, Andrea de Bartolomeis, Nico J.M. van Beveren, Michael L. Birnbaum, István Bitter, Alain Breier, Robert W. Buchanan, William T. Carpenter, David Castle, Eric Chen, Leslie Citrome, David Cotter, Christoph U. Correll, Benedicto Crespo‐Facorro, Michael Davidson, Richard Drake, Sonia Dollfus, Serdar Dursun, Bjørn H. Ebdrup, Robin Emsley, Emilio Fernández-Egea, Hélio Elkis, Peter Falkai, Wolfgang Fleischhacker, Oliver Freudenreich, Ary Gadelha, Wolfgang Gäebel, Birte Glenthøj, Donald Goff, Ariel Graff‐Guerrero, Jorge Hallak, Alkomiet Hasan, William G. Honer, Philip Homan, Oliver Howes, René S. Kahn, Stefan Kaiser, John M. Kane, James L. Kennedy, Bruce J. Kinon, Euitae Kim, Stephen M. Lawrie, Jimmy Lee, Stefan Leucht, F. Markus Leweke, Jan Libiger, Antony Loebel, James H. MacCabe, Stephen R. Marder, Robert A. McCutcheon, Ingrid Melle, Herbert Y. Meltzer, Armida Mucci, Dieter Naber, Shinchiro Nakajima, Jimmi Nielsen, Oisín O’Brien, Akin Ojagbemi, Christos Pantelis, Joseph Peuskens, Steven G. Potkin, Tiago Reis Marques, Thomas J. Raedler, Gary Remington, Susan L. Rossell, Jose Rubio-Lorente, Gabriele Sachs, Dan Siskind, Cynthia Siu, Iris E. Sommer, Jun Soo Kwon, Takefumi Suzuki, Jaana Suvisaari, Hiroyoshi Takeuchi, Rajiv Tandon, David Taylor, Neil Thomas, Jari Tiihonen, Hiroyuki Uchida, Alp Üçok, Daniel Umbricht, Ganesan Venkatasubramanian, Elias Wagner, James Walters, Chuanyue Wang ほか 2 名 - Schizophrenia Bulletin 2023 被引用: 38

  10. Impact of primary negative symptoms on functional outcomes in schizophrenia

    著者: Gagan Fervaha, George Foussias, Ofer Agid, Gary Remington - European Psychiatry 2014 被引用: 205

  11. Pharmacological interventions for prevention of weight gain in people with schizophrenia

    著者: Sri Mahavir Agarwal, Nicolette Stogios, Zohra Ahsan, Jonathan Lockwood, Markus J. Duncan, Hiroyoshi Takeuchi, Tony Cohn, Valerie H. Taylor, Gary Remington, Guy Faulkner, Margaret Hahn - Cochrane Database of Systematic Reviews 2022 被引用: 48

  12. Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial

    著者: Sri Mahavir Agarwal, Roshni Panda, Kenya A. Costa-Dookhan, Nicole E. MacKenzie, Quinn Casuccio Treen, Fernando Caravaggio, Eyesha Hashim, General Leung, Anish Kirpalani, Kelly Matheson, Araba Chintoh, Caroline K. Kramer, Aristotle N. Voineskos, Ariel Graff‐Guerrero, Gary Remington, Margaret Hahn - Translational Psychiatry 2021 被引用: 39

  13. Negative Symptoms in Schizophrenia: Avolition and Occam's Razor

    著者: George Foussias, Gary Remington - Schizophrenia Bulletin 2008 被引用: 586

  14. Negative symptoms of schizophrenia: Clinical features, relevance to real world functioning and specificity versus other CNS disorders

    著者: George Foussias, Ofer Agid, Gagan Fervaha, Gary Remington - European Neuropsychopharmacology 2013 被引用: 248

  15. An Algorithm-Based Approach to First-Episode Schizophrenia

    著者: Ofer Agid, Tamara Arenovich, Gautam Sajeev, Robert B. Zipursky, Shitij Kapur, George Foussias, Gary Remington - The Journal of Clinical Psychiatry 2011 被引用: 223

  16. Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment

    著者: Masataka Wada, Yoshihiro Noda, Yusuke Iwata, Sakiko Tsugawa, Kazunari Yoshida, Hideaki Tani, Yoji Hirano, Shinsuke Koike, Daiki Sasabayashi, Haruyuki Katayama, Eric Plitman, Kazutaka Ohi, Fumihiko Ueno, Fernando Caravaggio, Teruki Koizumi, Philip Gerretsen, Takefumi Suzuki, Hiroyuki Uchida, Daniel J. Müller, Masaru Mimura, Gary Remington, Anthony A. Grace, Ariel Graff‐Guerrero, Shinichiro Nakajima - Molecular Psychiatry 2022 被引用: 115

  17. Canadian Treatment Guidelines for Individuals at Clinical High Risk of Psychosis

    著者: Jean Addington, Donald Addington, Sabina Abidi, Thomas J. Raedler, Gary Remington - The Canadian Journal of Psychiatry 2017 被引用: 82

  18. Increased Stress-Induced Dopamine Release in Psychosis

    著者: Romina Mizrahi, Jean Addington, Pablo Rusjan, Ivonne Suridjan, Alvina Ng, Isabelle Boileau, Jens C. Pruessner, Gary Remington, Sylvain Houle, Alan A. Wilson - Biological Psychiatry 2012 被引用: 274

  19. Treatment Recommendations for Tardive Dyskinesia

    著者: Lucia Ricciardi, Tamara Pringsheim, Thomas R. E. Barnes, Davide Martino, David M. Gardner, Gary Remington, Donald Addington, Francesca Morgante, Norman Poole, Alan Carson, Mark J. Edwards - The Canadian Journal of Psychiatry 2019 被引用: 100

  20. Adherence to Oral Antipsychotics Measured by Electronic Adherence Monitoring in Schizophrenia: A Systematic Review and Meta-analysis

    著者: Hodaka Yaegashi, So Kirino, Gary Remington, Fuminari Misawa, Hiroyoshi Takeuchi - CNS Drugs 2020 被引用: 95

  21. Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review

    著者: Raghunath Singh, Nicolette Stogios, Emily R. Smith, Jiwon Lee, Kateryna Maksyutynsk, Emily Au, David C. Wright, Giada De Palma, Ariel Graff‐Guerrero, Philip Gerretsen, Daniel J. Müller, Gary Remington, Margaret Hahn, Sri Mahavir Agarwal - Therapeutic Advances in Psychopharmacology 2022 被引用: 40

  22. Treating Negative Symptoms in Schizophrenia: an Update

    著者: Gary Remington, George Foussias, Gagan Fervaha, Ofer Agid, Hiroyoshi Takeuchi, Jimmy Lee, Margaret Hahn - Current Treatment Options in Psychiatry 2016 被引用: 172

  23. Motivational Deficits and Cognitive Test Performance in Schizophrenia

    著者: Gagan Fervaha, Konstantine K. Zakzanis, George Foussias, Ariel Graff‐Guerrero, Ofer Agid, Gary Remington - JAMA Psychiatry 2014 被引用: 155

  24. The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review

    著者: Parita Shah, Yusuke Iwata, Eric Plitman, Eric E. Brown, Fernando Caravaggio, Julia Kim, Shinichiro Nakajima, Margaret Hahn, Gary Remington, Philip Gerretsen, Ariel Graff‐Guerrero - Psychiatry Research 2018 被引用: 96